Filing Manager
Voss Capital, LP
Reporting Manager
Voss Capital, LP
Symbol
ACTU
Shares outstanding
23,165,208 shares
Disclosed Ownership
1,227,756 shares
Ownership
5.3%
Form type
SCHEDULE 13G
Filing time
17 Dec 2025, 12:25:51 UTC
Date of event
15 Dec 2025
Next filing
22 Apr 2026

Quoteable Key Fact

"Voss Capital, LP disclosed 5.3% ownership in ACTUATE THERAPEUTICS, INC. Common Stock, par value $0.0001 per share (ACTU) on 15 Dec 2025."

Quick Takeaways

  • Voss Capital, LP filed SCHEDULE 13G for ACTUATE THERAPEUTICS, INC. Common Stock, par value $0.0001 per share (ACTU).
  • Disclosed ownership: 5.3%.
  • Date of event: 15 Dec 2025.

What Changed

  • No earlier schedule filing is available for direct comparison.
  • Current filing was accepted on 17 Dec 2025, 12:25.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Source Evidence

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (5)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Voss Capital, LP 5.3% 1,227,756 1,200,000 27,756 /s/ Travis W. Cocke Travis W. Cocke, Managing Member
Cocke Travis W. 5.3% 1,227,756 1,200,000 27,756 /s/ Travis W. Cocke Travis W. Cocke
Voss Advisors GP, LLC 1.1% 250,000 250,000 0 /s/ Travis W. Cocke Travis W. Cocke, Managing Member
Voss Value Master Fund, LP 0.9% 200,000 200,000 0 /s/ Travis W. Cocke Travis W. Cocke, Managing Member of Voss Advisors GP, LLC, its General Partner
Voss Value-Oriented Special Situations Fund, LP 0.2% 50,000 50,000 0 /s/ Travis W. Cocke Travis W. Cocke, Managing Member of Voss Advisors GP, LLC, its General Partner
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .